These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 7841103)
21. Presence of HIV-1 reverse transcriptase inhibitory antibodies in the sera of some HTLV-1 carriers and absence of neutralizing antibodies against HIV-1 in the sera of HTLV-1 carriers. Inoue M; Sei Y; Kashiwagi S; Shingu T; Yokoyama MM J Clin Lab Immunol; 1989 Apr; 28(4):173-7. PubMed ID: 2483412 [TBL] [Abstract][Full Text] [Related]
22. Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus. Presence at different clinical stages. Ljunggren K; Böttiger B; Biberfeld G; Karlson A; Fenyö EM; Jondal M J Immunol; 1987 Oct; 139(7):2263-7. PubMed ID: 3498755 [TBL] [Abstract][Full Text] [Related]
23. Serologic characterization of human immunodeficiency virus infection by Western blot and radioimmunoprecipitation assays. Resnick L; Shapshak P Arch Pathol Lab Med; 1987 Nov; 111(11):1040-4. PubMed ID: 3478005 [TBL] [Abstract][Full Text] [Related]
24. Enzyme immunoassays for the demonstration of antibodies to HIV-2SBL-6669 and HTLV-IV (SIVmac). Biberfeld G; Thorstensson R; Bergström M; Naucler A; Costa CM AIDS; 1988 Jun; 2(3):195-9. PubMed ID: 3134913 [TBL] [Abstract][Full Text] [Related]
25. Serological cross-reactivities between the retroviruses HIV and HTLV-1 and the malaria parasite Plasmodium falciparum. Elm J; Desowitz R; Diwan A P N G Med J; 1998 Mar; 41(1):15-22. PubMed ID: 10741173 [TBL] [Abstract][Full Text] [Related]
26. Specificity of anti-lymphocyte antibodies in sera from patients with AIDS-related complex (ARC) and healthy homosexuals. Warren RQ; Johnson EA; Donnelly RP; Lavia MF; Tsang KY Clin Exp Immunol; 1988 Aug; 73(2):168-73. PubMed ID: 3052941 [TBL] [Abstract][Full Text] [Related]
27. The spread of HIV-1 infection in Italy: seropositivity and AIDS related syndromes. Luzi G; Greco D; Sasse H; Rezza G; Aiuti F Allergol Immunopathol (Madr); 1991; 19(1):19-24. PubMed ID: 1950940 [TBL] [Abstract][Full Text] [Related]
28. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex]. Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856 [No Abstract] [Full Text] [Related]
29. Seroepidemiology of HTLV-I infection in northeast Thailand: a four year surveillance. Urwijitaroon Y; Barusrux S; Puapairoj C; Romphruk A; Khampeera P J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S102-5. PubMed ID: 9347655 [TBL] [Abstract][Full Text] [Related]
30. [Could saliva be used to detect HIV seroconversion?]. Sangaré KA; Koffi AR; Coulibaly IM; Doulourou C Sante; 1997; 7(5):303-7. PubMed ID: 9480036 [TBL] [Abstract][Full Text] [Related]
32. HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy. Manca N; Caruso A; Bonfanti C; Savoldi E; Li Vigni R; Pirali F; Sapelli PL; Turano A Eur J Epidemiol; 1989 Mar; 5(1):37-41. PubMed ID: 2707393 [TBL] [Abstract][Full Text] [Related]
33. [A study of sera positive and doubtful for antibodies to the human immunodeficiency virus for the presence of HTLV-I-specific antibodies]. Khaitov RM; Trubcheninova LP; Iakovleva LS; Glushchenko MV; Khabakhpasheva NA; Pavlish OA; Seniuta NB; Gurtsevich VE Vopr Virusol; 1991; 36(5):364-6. PubMed ID: 1803765 [TBL] [Abstract][Full Text] [Related]
34. Serological survey of HIV-1, HIV-2 and human T-cell leukemia virus type 1 for suspected AIDS cases in Ghana. Hishida O; Ayisi NK; Aidoo M; Brandful J; Ampofo W; Osei-Kwasi M; Ido E; Igarashi T; Takehisa J; Miura T AIDS; 1994 Sep; 8(9):1257-61. PubMed ID: 7802977 [TBL] [Abstract][Full Text] [Related]
35. Monoclonal-oligoclonal immunoglobulins in HTLV III infected subjects: HTLV III-induced or HTLV III-associated? Sala PG; Mazzolini S; Tonutti E; Crucil C; Pitzus E; Bramezza M Boll Ist Sieroter Milan; 1987; 66(1):14-7. PubMed ID: 3040040 [TBL] [Abstract][Full Text] [Related]
36. [Occurrence of HTLV-III infection and related clinical forms in a homogeneous group of drug addicts. Significance of immunologic changes and evaluation of risk factors]. Tassinari MC; Gualandi M; Guerra G; Barbieri D; Benassi N; Lazzarato M; Dallara G; Gallerani M Recenti Prog Med; 1986 Oct; 77(10):461-5. PubMed ID: 3547522 [No Abstract] [Full Text] [Related]
37. Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status. Franchini G; Robert-Guroff M; Aldovini A; Kan NC; Wong-Staal F Blood; 1987 Feb; 69(2):437-41. PubMed ID: 3467797 [TBL] [Abstract][Full Text] [Related]
39. Seroprevalence of anti-HTLV I/II and anti-HIV-1 antibodies in a sample population in the Marche Region, Italy. Mignini F; Quarenghi L; Cipriani S; Bartolucci M; Covelli I Eur J Epidemiol; 1994 Dec; 10(6):769-71. PubMed ID: 7672061 [TBL] [Abstract][Full Text] [Related]
40. Epidemiological survey of HIV infection in the Veneto region of Italy. Chieco Bianchi L; Faulkner Valle G; De Rossi A; Dalla Gassa O Biomed Pharmacother; 1987; 41(3):139-43. PubMed ID: 3038208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]